全文获取类型
收费全文 | 238847篇 |
免费 | 11238篇 |
国内免费 | 786篇 |
专业分类
耳鼻咽喉 | 3634篇 |
儿科学 | 7296篇 |
妇产科学 | 5876篇 |
基础医学 | 32733篇 |
口腔科学 | 8107篇 |
临床医学 | 16792篇 |
内科学 | 56426篇 |
皮肤病学 | 7584篇 |
神经病学 | 20231篇 |
特种医学 | 5607篇 |
外国民族医学 | 31篇 |
外科学 | 28664篇 |
综合类 | 1452篇 |
一般理论 | 64篇 |
预防医学 | 22945篇 |
眼科学 | 4695篇 |
药学 | 16794篇 |
中国医学 | 1160篇 |
肿瘤学 | 10780篇 |
出版年
2023年 | 1463篇 |
2022年 | 2869篇 |
2021年 | 6153篇 |
2020年 | 3230篇 |
2019年 | 5690篇 |
2018年 | 7619篇 |
2017年 | 4754篇 |
2016年 | 4808篇 |
2015年 | 5286篇 |
2014年 | 7351篇 |
2013年 | 10424篇 |
2012年 | 15660篇 |
2011年 | 16622篇 |
2010年 | 8988篇 |
2009年 | 7684篇 |
2008年 | 13269篇 |
2007年 | 13844篇 |
2006年 | 13161篇 |
2005年 | 13121篇 |
2004年 | 11817篇 |
2003年 | 11090篇 |
2002年 | 10375篇 |
2001年 | 6661篇 |
2000年 | 7158篇 |
1999年 | 5917篇 |
1998年 | 1762篇 |
1997年 | 1373篇 |
1996年 | 1219篇 |
1995年 | 1053篇 |
1994年 | 869篇 |
1993年 | 782篇 |
1992年 | 2600篇 |
1991年 | 2339篇 |
1990年 | 2158篇 |
1989年 | 1866篇 |
1988年 | 1674篇 |
1987年 | 1558篇 |
1986年 | 1511篇 |
1985年 | 1361篇 |
1984年 | 1001篇 |
1983年 | 880篇 |
1979年 | 928篇 |
1978年 | 654篇 |
1975年 | 653篇 |
1974年 | 773篇 |
1973年 | 788篇 |
1972年 | 679篇 |
1971年 | 686篇 |
1970年 | 649篇 |
1969年 | 663篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
Uptake of Adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas 总被引:1,自引:0,他引:1
H. von Holst E. Knochenhauer H. Blomgren V. P. Collins L. Ehn M. Lindquist G. Norén C. Peterson 《Acta neurochirurgica》1990,104(1-2):13-16
Summary Eight patients with malignant gliomas verified on CT scan, received an intravenous injection of 50 mg of Adriamycin R, 24 hours prior to surgical removal of the tumour. Peroperatively, both tumour and surrounding tissue specimens were obtained for determination of the tissue concentrations of Adriamycin and its reduced metabolite Adriamycinol. It was found that Adriamycin could be detected in tumour tissue from all patients. The concentration varied between 0,9 and 4,6 nmol/g tissue. In contrast, Adriamycin could only be detected in surrounding brain tissue from one patient.In anin vitro study a human malignant glioma cell line (U-251 MG) was exposed to various concentrations of Adriamycin for 24 hours. It was found that an intracellular drug concentration above 30 nmol/g cells caused a concentration dependent inhibition of cell growth. Thus, it is likely that the poor effect of Adriamycin on patients with malignant gliomas is due to an ineffective drug accumulation in the tumour tissue. 相似文献
44.
The present authors investigated the excretion, distribution and pharmacokinetics of the novel potential antirheumatic agent flobufen and its active metabolite after p.o. and i.v. doses of 2, 10 and 50 mg/kg administered to rats. The drug is resorbed well from the digestive tract and mostly it is metabolized to the principal metabolite M, which is only slowly excreted from the organism mainly by renal clearance. Within the whole dose range the kinetics of the drug is linear. Binding of flobufen and M to proteins is high (95-99%). The highest concentrations of radioactive metabolites (mostly M) were found in the plasma, liver, lungs, kidneys, connective tissue and inflammatory foci. The penetration of metabolites through the placenta and excretion in human milk are relatively important. 相似文献
45.
46.
47.
Summary In cases where a reconstruction of defects in the larynx, oral cavity, the pharynx or in the ear region has been performed using skin flaps, a temporary fistula is formed at the point of entry.This fistula can be closed later after the flap has taken and the flap pedicle dissected.We would like to demonstrate with some examples that with the use of deepithelisation it is possible to achieve a primary wound closure. This way no temporary fistula results and additional surgery is avoided in many cases.Furthermore flap deepithelisation offers a way to bring good vascularised tissue under the skin and cover subcutaneous defects, for example those after radiotherapy.
Die Veröffentlichung des Manuskripts soll in Laryngol Rhinol Otol (Stuttg) erfolgen 相似文献
Die Veröffentlichung des Manuskripts soll in Laryngol Rhinol Otol (Stuttg) erfolgen 相似文献
48.
49.
Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up 总被引:1,自引:0,他引:1
A retrospective study of 232 bladder tumours with minimum follow-up 5 years is presented. The carcinoma was superficial in 66%, muscle-invasive in 31% and could not be staged in 3%. Primary treatment was mainly transurethral resection for superficial tumour, but was cystectomy or radiotherapy in 22 of 29 T1 G3. Of the superficial tumours, 71% recurred. Progression to higher T stage occurred in 15% of Ta and 29% of T1 tumours, and half of these patients died of bladder cancer. The corrected 5-year survival rates in grades 1, 2A, 2B and 3-4 were 96, 84, 64 and 43%, and in stages Ta, T1, T2 and T3 they were 94, 69, 40 and 31%. All patients with T4 tumour died within 4 years. Among the 45 patients with 40 Gy irradiation + cystectomy, the corrected 5-year survival rate was 83% in superficial and 64% in muscle-invasive tumours, and among the 38 with radical radiotherapy the rates in T1-3 were 46, 36 and 13%. Transurethral resection was successful in most Ta cases. Most T1 tumours were, like T2-4, of higher grade than Ta. Prognosis was worse in T1 than in Ta. After progression to muscle-invasive disease, even during close follow-up the outlook was poor, as poor as for patients with primary muscle-invasive disease. 相似文献
50.
Mikael Hellström Bo Jacobsson Ulf Jodal Jan Winberg Anders Odén 《Pediatric nephrology (Berlin, Germany)》1987,1(3):269-275
This study presents the result of 12–21 years' follow-up in a group of children with neonatal urinary tract infection (onset within 1 month after birth) in whom early renal growth retardation was noted without concomitant classical renal scarring. In all cases the neonatal infection was diagnosed and treated within a few days of onset and the patients were closely supervised thereafter. Renal length, parenchymal thickness and area were measured at urography. At first follow-up (22 children, mean age 4.1 years) a significant reduction of renal parenchymal thickness was noted. Long-term follow-up (18 patients, mean age 17 years) demonstrated a normalization of renal size in the entire group, although less complete in the subgroup with reflux. There were two major findings in the present study. Firstly, renal growth retardation was seen after neonatal infection, both with and without reflux. Secondly, normalization of renal size in previously small kidneys was demonstrated, suggesting that growth retardation can be a reversible phenomenon. The tendency for such normalization was slightly more marked in children without reflux. Reduction of parenchymal thickness without calyceal deformity, therefore, does not necessarily mean irreversible damage, and differentiation between permanent scarring and temporary growth retardation can thus only be made at later follow-up, possibly not until after puberty. The demonstration of renal growth retardation in spite of early diagnosis and treatment emphasizes the great vulnerability of the kidney in the newborn. 相似文献